Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study

BACKGROUND: Tigecycline is a vital antibiotic treatment option for infections caused by multiresistant bacteria in the intensive care unit (ICU). Acute kidney injury (AKI) is a common complication in the ICU requiring continuous renal replacement therapy (CRRT), but pharmacokinetic data for tigecycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Broeker, A., Wicha, S. G., Dorn, C., Kratzer, A., Schleibinger, M., Kees, F., Heininger, A., Kees, M. G., Häberle, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296114/
https://www.ncbi.nlm.nih.gov/pubmed/30558639
http://dx.doi.org/10.1186/s13054-018-2278-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296114/
https://www.ncbi.nlm.nih.gov/pubmed/30558639
http://dx.doi.org/10.1186/s13054-018-2278-4

Ejemplares similares